A few years later, Sato and colleagues failed to see any direct association of CD25+FOXP3+ T cells in ovarian cancer, but did show that low total CD8+ T cell counts and the CD8+/CD25+FOXP3+ T cell ratio were associated with poorer survival, again in a population with varying histologies [8]. This evidence concerns the gene CD8A and ovarian cancer.